Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-25-223384
Filing Date
2025-09-29
Accepted
2025-09-29 16:59:05
Documents
1
Period of Report
2025-09-25

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 3858
  Complete submission text file 0001193125-25-223384.txt   5285
Mailing Address 900 FIFTH AVENUE #8C NEW YORK NY 10021
Business Address
Gottesdiener Keith Michael (Reporting) CIK: 0001615856 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-42382 | Film No.: 251357055

Mailing Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080
Business Address 250 EAST GRAND AVENUE, SUITE 65 SOUTH SAN FRANCISCO CA 94080 650-338-3533
Septerna, Inc. (Issuer) CIK: 0001984086 (see all company filings)

EIN.: 843891440 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)